Alfonso Vera-Barajas

The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis

N. Méndez-Sánchez, D. Zamora-Valdés, G. Ponciano-Rodríguez, 2020, Annals of translational medicine.

Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis

A. Panduro, N. Méndez-Sánchez, V. Cruz-Ramon, 2020, F1000Research.

New insights into the association between non-alcoholic fatty liver disease and atherosclerosis.

N. Méndez-Sánchez, Beatriz Barranco-Fragoso, X. Qi, 2019, Annals of translational medicine.

New therapeutic options for bile acid malabsorption diarrhea.

N. Méndez-Sánchez, X. Qi, Alejandro Valencia-Rodríguez, 2019, Annals of translational medicine.

Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease

N. Chavez-Tapia, M. Uribe, N. Méndez-Sánchez, 2020, Annals of Hepatology.

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer

L. Abenavoli, N. Méndez-Sánchez, E. Scarpellini, 2020, Hepatoma research.